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Background: It is well known that information about clinical trials is not easily accessible by the public. In Japan,
clinical trial information can be accessed by the general public through online registries; however, many people
find these registries difficult to use. To improve current clinical trial registries, we propose that combining them
with clinical information phrased in lay terms would be beneficial to other interested professionals such as
journalists and clinicians, as well as the general public. Therefore, this study aimed to examine the current pattern
of distribution of clinical trial information from the primary World Health Organization (WHO) registries. Based on
the results of this assessment, we then aimed to build and evaluate a prototype of the Japan Primary Registries
Network (JPRN) portal that would be easily accessible to patients and the public, while still remaining useful for
professionals.
Methods: We assessed a total of 14 primary clinical trial registries listed on the WHO International Clinical Trials
Registry Platform between January and February 2013. Website content was accessed and checked against a series
of items that looked at usability, communication, design and accessibility of the sites. We excluded registries that
were not active or were not on the approved WHO registry list at the time of our assessment. We also examined
only the English versions of the websites as native-language registries may offer more functionality or different
content than the English version of the same website.
Results: All registries examined had a function allowing users to search the registry data and that displayed the
related information from the search, including the clinical trial registration data. However, few websites were found
to be user-friendly, and there was little integration with social media.
Conclusions: We confirmed that there are few websites providing useful clinical trial information to patients and
their families. However, information gleaned from some of the more advanced online registries could be used to
improve the content and functionality of the JPRN portal.
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The Japan Primary Registries Network (JPRN) is main-
tained by the Ministry of Health, Labour and Welfare in
Japan (MHLW) and the National Institute of Public
Health, Japan, which hosts the Clinical Trials Search por-
tal [1]. The network comprises three primary registries:
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Trials Information [3] and Japan Medical Association’s
Center for Clinical Trials [4]. The JPRN portal was recog-
nized as a World Health Organization (WHO) primary
registry in 2008. It collects and manages clinical trial data
in both Japanese and English. Several problems with the
website have been pointed out by the clinical trial activa-
tion committee, including that patients found the portal
difficult to use [5].
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Japan Japan Primary Registries Network (JPRN)
http://rctportal.niph.go.jp/





Australian New Zealand Clinical Trials Registry (ANZCTR)
http://www.anzctr.org.au/
Brazil Brazilian Clinical Trials Registry (ReBec)
http://www.ensaiosclinicos.gov.br/
China Chinese Clinical Trial Registry (ChiCTR)
http://chictr.clinicaltrialecrf.org/en/
(http://www.chictr.org/en/)
South Korea Clinical Research Information Service (CRiS)
http://ncrc.cdc.go.kr/cris/en/use_guide/cris_introduce.jsp
(https://cris.nih.go.kr/cris/en/use_guide/cris_introduce.jsp)
Cuba Cuban Public Registry of Clinical Trials (RPCEC)
http://registroclinico.sld.cu/
EU EU Clinical Trials Register (EU-CTR)
https://www.clinicaltrialsregister.eu/
Germany German Clinical Trials Register (DRKS)
https://drks-neu.uniklinik-freiburg.de/drks_web/
Iran Iranian Registry of Clinical Trials (IRCT)
http://www.irct.ir/
UK International Standard Randomised Controlled Trial
Number Register (ISRCTN)
http://www.isrctn.org/
Netherlands Netherlands National Trial Register (NTR)
http://www.trialregister.nl/trialreg/index.asp
Pan Africa Pan African Clinical Trial Registry (PACTR)
http://www.pactr.org/
Sri Lanka Sri Lanka Clinical Trials Registry (SLCTR)
http://www.slctr.lk/
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goal is that patients and the public should be able to ac-
cess the JPRN portal and learn from the clinical trial in-
formation stored within it, while researchers and
clinicians can use the clinical trials information to help
produce new innovations in Japanese medical treatment,
such as new drugs [6]. Therefore, to improve the JPRN
portal, we suggest that the current portal is combined
with clear clinical information in lay terms to enhance
the usability and understanding of clinical trials and
other medical research (currently the portal does not
focus exclusively on clinical trials, but also provides gen-
eral medical information to the public) by the general
public and any interested professionals [5,6]. We propose
that sharing the challenges of providing information be-
tween three data providers and the government would
provide cohesive benefits for the JPRN. It would be pos-
sible to carry out joint improvement activities such as sys-
tem maintenance, data formatting and quality control of
the registration data. This could improve the system, in-
cluding the website, while maintaining coordination with
the network of the primary registry. Modification of the
present Japanese clinical trial search portal site would ad-
dress users’ requests for a more user-friendly and conveni-
ent website for all users, including patients and their
families, medical professionals, pharmaceutical companies
and researchers. Promoting participation in clinical trials
and a greater understanding of clinical research would
also be beneficial to the public [7]. Furthermore, an im-
provement in the quality of clinical trials, such as those in-
vestigating innovative new drugs, would be likely.
To determine the current pattern of distribution of clin-
ical trial information from the WHO primary registries,
an assessment needs to be conducted for each website.
Based on the results of this assessment, a system proto-
type that could be easily accessed by patients and the gen-
eral public and that would still be useful for medical
professionals, could be built and evaluated against the
goals proposed above.
Methods
The websites of 14 clinical trial databases were assessed
between January and February 2013. ClinicalTrials.gov
(CT.gov) [8] and 13 primary registries listed in the
WHO International Clinical Trials Registry Platform
(ICTRP) [9] were included in this study (Table 1). We
evaluated each registry against a checklist comprising 16
items related to website content (Table 2), 18 items on
navigation, search and whether the website could be
used in multiple languages (hereafter, referred to as multi-
lingualization; Table 3), and 19 items related to website
function, communication, design and accessibility (Table 4).
All 14 websites were assessed by a web designer and devel-
oper. The checklist was prepared by all authors following areview of the literature. We focused on problems identified
by the MHLW Clinical Trial Activation Committee [5] and
the National Cancer Institute (NCI) International Clinical
Trials Portal Website Usability Test Report [10].
The assessment results were analyzed to determine
patterns in how clinical trial information was provided.
We assessed only the English versions of the included
registries (with the exception of the JPRN portal site, for
which the Japanese version was assessed), as native-
language versions of these websites may offer more func-
tions or different content than the English versions.
With respect to institutional review board (IRB) infor-
mation, because we only searched the English websites
of each registry, it is possible that information was
missed if it was included using terms other than ‘IRB’ or
was written in the authors’ native language. The IRB
Table 2 Website content
Assessment item JPRN CT.gov ANZCTR ReBec ChiCTR CRiS RPCEC EU CTR DRKS IRCT ISRCTN NTR PACTR SLCTR
Pages for each type of user,
such as patients and health
professionals
No Partly No No No No No No No No No No No No
Content for each type of user,
such as patients, health
professionals and clients
No Partly No No No No No No No No No No No No
Clinical trial information
pages (patient)
– – – – – – – – – – – – – –
Clinical trial information
pages (health professional)
– – – – – – – – – – – – – –
Information pages on
diseases (patient)




No No No No No No No No No No No No No No
Links to information on
diseases, drugs or treatments
No No No No No No No No No No No No No No
List of ongoing clinical
trial information
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Information on the institutional
review board (IRB)
No Partly No No No No No No Partly No No No No Partly
IRB information page (patient) – Partly No No No No No No No No No No No No
IRB information page (health
professional)
– No No No No No No No No No No No No No
Use of videos and images No No No No No No No No No No No No No No
Frequently asked questions
(patient)
Yes Partly No No Yes No No Yes Yes Yes No No Yes Yes
Frequently asked questions
(health professional)
– – Yes Yes No No No – – – Yes No – –
Glossary (patient) Yes Yes No No No No No Yes Yes No No No No No
Glossary (health professional) – – No No No No No – – No – No No No
‘No’ encompasses ‘not provided’, ‘no description’ and ‘no distinction’. A dash (–) indicates that the response is summarized in the answer of another item or could
not be evaluated.
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with other ethics committee information. This was a
limitation here, in that we were not able to check in the
native language of the registry whether the item had
been provided. We excluded registries that were either
not active or that were not on the WHO list of approved
registries at the time of our assessment. We did not cor-
respond with the administrators of any of the registries
to clarify, supplement or verify the information ex-
tracted. The assessment was completed based on the in-
formation provided on each of the 14 registry websites.
Results
Website content
The CT.gov website contained content and parts of pages
devoted to each type of user (laypeople and professionals
such as clinicians, funders, journal editors, journalists, sys-
tematic reviewers and researchers), although the distinc-
tion was not always clear. None of the 14 websites hadseparate pages with information on clinical trial informa-
tion, disease information, medicine and treatments for dis-
eases, or links to similar information. All 14 websites had
a list of ongoing clinical trial data. Eleven websites incor-
porated frequently asked questions, and four websites in-
cluded a glossary (Table 2).
Website multilingualization, navigation and search
Regarding the use of multiple languages on the websites,
organizations with a native language other than English
were presumed to use multiple languages. Global naviga-
tion was one of the usability items assessed. Global naviga-
tion systems place page links onto the website homepage,
and function as a shortcut to the content of the website.
Global navigation can help users understand the complete
scope of the website or their current position in the web-
site. Breadcrumb navigation displays web pages within a
hierarchy on the website. This display makes it easy to de-
termine where the user is located within the website and
Table 3 Website multilingualization, navigation and search
Assessment item JPRN CT.gov ANZCTR ReBec ChiCTR CRiS RPCEC EU CTR DRKS IRCT ISRCTN NTR PACTR SLCTR
Multilingualization
Multilingualization of website Yes No No Yes Yes Yes Yes No Yes Yes Yes No No No
Multilingualization of contact
information
Yes – – No Yes Yes Yes – Yes Yes No Yes No No
Multilingualization of clinical trial
information
Yes – – Yes Yes Yes Yes – Yes Yes No No No No
Navigation
Includes ‘clinical trial’ in the global
navigation
No Yes Yes Yes Yes No No No No No No No No No
Global navigation includes the
roles ‘patient’ and ‘health
professionals’
No Partly No No No No No No No No No No No No
Minimum number of clicks to
access clinical trial information
(patient)
1 1 – – – No No No No No No No No No
Minimum number of clicks to access
clinical trial information (health
professional)
– 1 – – – No No No No No No No No No
Minimum number of clicks to
access clinical trial information
(practitioner)
– 1 – – – No No No No No No No No No
Easy access to clinical trial
information
Yes Yes – – – No – Partly – – Yes – – –
Breadcrumb navigation Yes Yes No Yes No No Yes No No No No No No No
Search
Search for clinical trial information Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes

































Display contents of search results 6 items 4 items 6 items 4 items 4 items 2 items 1 item 13 items 3 items 1 item 4 items 3 items 4 items 1 item
Overview display of search results
for patients
No No Yes No No No No No No Yes No No No No
Clinical trial search for each specific
disease area
No No No No No No No No No No No No No No
Information regarding past clinical
trials
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Information regarding clinical trials
conducted in other facilities
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Keyword shortcut to search No No No No No Yes No No No No No No No No















Table 4 Website function, communication, design and accessibility
Assessment item JPRN CT.gov ANZCTR ReBec ChiCTR CRiS RPCEC EU CTR DRKS IRCT ISRCTN NTR PACTR SLCTR
Function
Clinical trial data output
(RSS, XML or CSV)
No Yes Yes Yes No Yes No Yes Yes No No No No No
Function to evaluate the
content
No No No No No No No No No No No No No No
Function to submit
opinions and requests
Partly Yes Yes No No No No Yes Yes No Partly No Yes No
Communication
Use of social media No No No No No No No No No No Yes No No No
Email address Partly No Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes
Phone number Yes No Yes Yes Yes Yes Yes No Yes Yes Yes No Yes Yes
Fax number Yes No Yes No Yes Yes No No Yes Yes Yes No Yes Yes
Transportation guide Yes No No No No – No No No No No No No No
Inquiry form Yes Yes Yes Yes No – Yes No Yes Yes No No Yes No
Contact for each purpose Yes No No No No – No No No No No No No No
Alternate contact method No No No No No No No No No No No No No No
How to apply for the
clinical trial
No Yes No No No No No No No No No No No No
Apply for the clinical
trial from the website




No No No No No No No No No No No No No No
Website compatible with
feature phones
No No No No No No No No No No No No No No
Website compatible with
tablets
No No No No No No No No No No No No No No
Accessibility
Font size No No No No No No Yes No Yes No No No Yes No
Images with alt attribute Yes Yes Yes Yes Partly Partly Yes Yes Yes No No Partly Partly No
Elimination of layout
by < table > tag
Yes Yes Yes Yes Yes Yes Yes No Yes No No No Yes No
‘No’ encompasses ‘not provided’, ‘no description’ and ‘no distinction’. A dash (–) indicates that the response is summarized in the answer of another item or could
not be evaluated.
CSV, comma-separated values; RSS, RDF site summary; XML, extensible markup language.
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links, making the website easier to navigate. We assessed
each website in terms of what was displayed in the banner
area on the homepage and the global navigation system by
which users can move around the site. Four websites in-
cluded ‘clinical trial’ in their global navigation options,
four websites facilitated easy access to clinical trial infor-
mation, and four websites had breadcrumb navigation fea-
tures. The definition of ‘easy access’ followed NCI
recommendation 7 in the Website Usability Test Report
[10]: ‘Redesign the home page to reduce the amount of
text and make links to important topics on third-level
pages visible’.
As CT.gov was the only website to offer a separate page
for each user type, it was also the only registry to whichcertain items applied: ‘Global navigation includes the roles
“patient” and “health professionals”’, and ‘Minimum num-
ber of clicks to access clinical trial information’.
All registry websites had a search function for clinical
trial information and displayed information on past clin-
ical trials and trials conducted in other facilities. A few
websites had functions such as an overview display of
search results for patients, and keyword shortcuts for
searching (Table 3).
Website function, communication, design and accessibility
Website function and communication
Six websites had an output function for clinical trial data:
data could be retrieved in RSS (RDF site summary), XML
(extensible markup language) or CSV (comma-separated
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submit opinions and requests. However, no website had a
function to allow users to evaluate the website content.
The International Standard Randomised Controlled Trial
Number Register (ISRCTN.org) site [11] was the only
website that used social media (Twitter).
Website design and accessibility
None of the websites were designed to be natively com-
patible with smartphones, feature phones or tablets.
Three websites included features to adjust the font size.
The aim of the JPRN portal site is to be accessible to all
people, including disabled people. The following items
were included in the category for accessibility.
Alt attributes, cascading style sheets (CSS) and table-
less design are relevant for accessibility. The alt attribute
is the alternative text attached to an image. For users
who need a voice browser, it is the string that can be
read by a text-to-speech browser and that is displayed
when the image is not found. Six websites attached an
alt attribute almost perfectly; however, images were not
widely used on three websites. Use of a CSS layout (used
instead of a table layout) along with the < table > tag to
present data as a table, avoids the use of tables as a
basis for the entire webpage layout (which was a feature
of earlier web browsers). Without this feature, for users
who need a voice browser, it is not possible to distrib-
ute the contents accurately because the structure of the
content is dependent on appearance. The layouts of
seven websites used CSS instead of the table layout
using the < table > tag (Table 4).
Discussion
The results of this assessment demonstrate that few
websites (particularly those in a native language other
than English) were easily accessible by patients and the
general public for locating information on clinical trials.
Currently, the NCI [12] website allows users to search
for clinical cancer trials using data imported from CT.
gov. Before CT.gov began to administer the website,
NCI had its own original database of clinical trials from
the 1970s. At that time, there were two versions of trial
descriptions, one for health professionals and one for pa-
tients. The patient version displayed optional informa-
tion on the purpose, eligibility, treatment/intervention,
lead organizations, trial sites and contacts. Moreover, the
current NCI website is a very good example of efforts to
create and improve a website for patients and the general
public. Dear et al. pointed out that the most important
additional item for website users was the lay summary
[13,14]. With an overview display of clinical trial search
results, patients and the public can easily understand the
contents and whether particular clinical trials are associ-
ated with their disease. In addition, a lay summary of theinformation may help in their decision-making regarding
which clinical trials to join [15].
Several problems with clinical trial registry websites
that we encountered were identified by the Clinical Trial
Activation Committee [5]. One issue is that people can-
not find information on the clinical research or trials re-
lated to their own diseases, e.g., how many clinical trials
are being conducted or if they are taking place at a
nearby location. It is also a problem that the total num-
ber of clinical trials that have been conducted in Japan
cannot be calculated (some clinical trials conducted in
Japan were registered in overseas registries). Grobler
et al. pointed out the problem of duplicate trial regis-
tration [15,16]. Some organizations have already iden-
tified this as an important issue, and several (e.g. CT.
gov and ICTRP) have made efforts to reduce duplicate
registrations by using unique identifiers. To avoid
publication bias and selective reporting, the WHO
Trial Registration Data Set comprising 20 data ele-
ments has been approved by the International Com-
mittee of Medical Journal Editors [9,17,18]. However,
only a few items pertain to those patients and individ-
uals in the general population who are asking for spe-
cific and prioritized information. Some of the
requested data elements may be unavailable to them.
Further investigation is needed to determine which in-
formation is most desired by patients and the general
public.
We have not yet had much opportunity to ascertain
user opinions about the JPRN portal. Despite limited
personnel and budget, there is a need to continuously
improve the website and to evaluate the site contents by
methods such as satisfaction surveys. CT.gov and NCI
conduct a standard survey to address this need: the
American Customer Satisfaction Index Online Con-
sumer Survey [19]; however, other surveys regarding
website usability and internet user satisfaction were not
found in this study. To improve a website, at the very
least, current information is required on how users ac-
cess the website and use the search function. Access log
analysis is one way to understand the behavior of inter-
net information seekers [20,21]. Another option is the
use of website evaluations that are accessible and user-
friendly and therefore provide a good opportunity for re-
ceiving feedback directly from users. However, feedback
should be verified against the content provided and the
actual information requested by users [22-24]. Improved
accessibility of websites is likely to make a good impres-
sion on all users.
CT.gov's clinical trials database is the largest of all the
organizations assessed (excluding ICTRP), and it has a
long history of system operation and system manage-
ment [25]. Clinical trial registration is required by fed-
eral law in the United States [26-29] and by the
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Japan, there is currently no such legislation. If such legis-
lation were introduced, it might be possible for the JPRN
to create a common format or dataset, and the addition
of common data elements for clinical trial registration
(excluding the 20 minimum data elements proposed by
WHO [31]) could proceed and be harmonized smoothly.
In addition, the current JPRN website does not offer a
means for clinical trial data output. This limits distribu-
tion to the public, except via the ICTRP, because there is
no authentication of the data provided by the three orga-
nizations. In addition, there are a few unique problems
with the JPRN portal site: it is not linked to an adequate
number of hospitals or associations; few of the general
public know of its existence or how to access it; and pa-
tients and the public are not aware of the useful infor-
mation it contains [32,33]. It is possible that the
National Institute of Public Health will begin to play a
role in the management and distribution of clinical re-
search and clinical trial information in Japan. There are
still many challenges for organizations to overcome, in-
cluding the distribution of clinical trial information to
patients and their families [15,34,35]. A big challenge is
the format of the data in JPRN: a different Japanese for-
mat and system are used by each of the three organiza-
tions. Therefore, it is necessary to reform the legal
system with respect to new data input into the portal; it
should be mandated that lay terms be provided at regis-
tration to enable patients and the general public to
understand them more easily.
Conclusions
In this study, the content and the characteristics of the on-
line registry systems were found to be different for each
organization. We confirmed that there were few websites
that provided useful clinical trial information to patients
and the general public. It is likely that the number of years
of website operation, the amount of integrated data col-
lected on clinical trials, and regional characteristics and
resources (personnel and budget) differ by organization
and thus affect their content and design. Moreover, con-
cerning the dissemination of their services to patients and
the public, we discovered room for improvement in the
JPRN content and website systems. It follows that there
may be other organizations that have similar challenges.
The distribution of clinical trial information to inter-
ested parties continues to be a challenge for WHO pri-
mary registries. Recommendations to improve the content
and functions of these registries (including the JPRN) can
be made based on advanced versions of other current
websites, specifically, CT.gov and the NCI website.
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